Medtronic Wins FDA Nod for Guardian Sensor

The FDA cleared Medtronic‘s Guardian sensor, part of the Medtech’s MiniMed 670G automated insulin delivery system.

The device is a continuous glucose monitor and is used with a hybrid-closed loop system to control insulin delivery.

The system uses Medtronic’s SmartGuard algorithm to automatically adjust insulin delivery every five minutes based on data provided by the Guardian Sensor 3.